MA

Active Director Additional Director DIN 10538175
DIN 10538175 First appointment Mar 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value •••• Premium profile

About Mohd Arif

Data last updated:

Mohd Arif is an Additional Director at Alig Pharma Private Limited (since 2024). The company operates in Healthcare. Alig Pharma Private Limited reported revenue of ₹2 Lakh (FY 2025).

DIN 10538175
Primary Designation Additional Director
Industry Healthcare
First Appointment 07 Mar 2024
Oldest Company Age 4 yrs
Largest company Alig Pharma Private Limited · ₹2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alig Pharma Private Limited U85100DL2022PTC392947
Additional Director07 Mar 20242022₹2 Lakh (FY 2025)Active

Board colleagues of Mohd Arif

NameDINCompanyDesignation
Ishtiyaq Hussain09482527Alig Pharma Private LimitedDirector
Mubeen09482526Alig Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alig Pharma Private Limited
Premium access

Shareholding and investment profile for Mohd Arif

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohd Arif

Mohd Arif currently holds 1 directorship: Alig Pharma Private Limited (Additional Director, since 07 Mar 2024, revenue ₹2 Lakh (FY 2025)).

Mohd Arif was first appointed on 07 Mar 2024 as Additional Director at Alig Pharma Private Limited.

The current boards of Mohd Arif's companies include Ishtiyaq Hussain (Alig Pharma Private Limited), Mubeen (Alig Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available